Novosti
Khirurgii

 This journal is
indexed in Scopus
journal cover
android icon Android Applicaion

Year 2019 Vol. 27 No 6

EXCHANGE OF EXPERIENCE

A.M. OVECHKIN, S.V. SOKOLOGORSKIY, M.E. POLITOV

OPIOID-FREE ANAESTHESIA AND ANALGESIA – TRIBUTE TO FASHION OR THE IMPERATIVE OF TIME?

I.M. Sechenov First Moscow State Medical University, Moscow,
The Russian Federation

Opioid analgesia continues to be the “gold standard” of postoperative analgesia in most developed countries. At the same time, in recent years, evidence has been accumulated indicating the negative impact of opioids on the course of the early postoperative period. In addition to the traditional side effects of these drugs (depression of consciousness, excessive sedation, nausea, etc.), their ability to form opioid-induced hyperalgesia, to have an immunosuppressive effect, to reduce the power of local anesthetics is considered. In addition, opioid analgesia prevents the implementation of the concept of accelerated postoperative patient rehabilitation (fast-track surgery and ERAS). The review examines the modern possibilities of conducting free or low-opioid anesthesia, mainly during laparoscopic surgery. The concept of multimodal analgesia makes it possible to refuse the use of opioid analgesics or to minimize their dosage in the perioperative period. Multimodal analgesia involves the simultaneous administration of two or more drugs that affect different levels of the formation of acute pain. The characteristics of the main components of opioid-free anesthesia and analgesia (NSAIDs, paracetamol, dexmedetomidine, gabapentin, ketamine, lidocaine, dexamethasone) are described from the standpoint of evidence-based medicine. The schemes of opioid-free anesthesia and analgesia in a number of surgeries are presented, in particular, with laparoscopic cholecystectomy and laparoscopic hemicolectomy.

Keywords: opioid-free anesthesia, analgesia, multimodal analgesia, NSAID, dexmedetomidine, gabapentin, lidocaine, ketamine, dexamethasone
p. 700-715 of the original issue
References
  1. Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013 Mar;27(1):62-70. doi: 10.3109/15360288.2012.751956
  2. Clark DJ, Schumacher MA. America’s Opioid Epidemic: Supply and Demand Considerations. Anesth Analg. 2017 Nov;125(5):1667-74. doi: 10.1213/ANE.0000000000002388
  3. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002 Jun;3(3):159-80. doi: 10.1054/jpai.2002.123652
  4. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, Rublee D, Samore MH. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007 Mar;41(3):400-6. doi: 10.1345/aph.1H386
  5. Pizzi LT, Toner R, Foley K, Thomson E, Chow W, Kim M, Couto J, Royo M, Viscusi E. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy. 2012 Jun;32(6):502-14. doi: 10.1002/j.1875-9114.2012.01101.x
  6. Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013 Apr;33(4):383-91. doi: 10.1002/phar.1223
  7. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience. 1998 May;84(2):583-89. doi: 10.1016/S0306-4522(97)00556-3
  8. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg. 2002 May;94(5):1263-69, table of contents. doi: 10.1097/00000539-200205000-00040
  9. Singleton PA, Moss J. Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010 Aug;6(8):1237-42. doi: 10.2217/Fon.10.99
  10. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006 Nov 17;127(4):679-95. doi: 10.1016/J.Cell.2006.11.001
  11. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, Bessler H. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996 Mar;82(3):492-97. doi: 10.1097/00000539-199603000-00011
  12. Vosoughian M, Dabbagh A, Rajaei S, Maftuh H. The duration of spinal anesthesia with 5% lidocaine in chronic opium abusers compared with nonabusers. Anesth Analg. 2007 Aug;105(2):531-33. doi: 10.1213/01.Ane.0000268496.46141.4f
  13. Hashemian AM, Omraninava A, Kakhki AD, Sharifi MD, Ahmadi K, Masoumi B, Mehrpour O. Effectiveness of local anesthesia with lidocaine in chronic opium abusers. J Emerg Trauma Shock. 2014 Oct;7(4):301-4. doi: 10.4103/0974-2700.142765
  14. Liu Q, Gold MS. Opioid-induced Loss of Local Anesthetic Potency in the Rat Sciatic Nerve. Anesthesiology. 2016 Oct;125(4):755-64. doi: 10.1097/ALN.0000000000001239
  15. Ulbricht W. Sodium channel inactivation: molecular determinants and modulation. Physiol Rev. 2005 Oct;85(4):1271-301. doi: 10.1152/physrev.00024.2004
  16. Ferrini F, Trang T, Mattioli TA, Laffray S, Del’Guidice T, Lorenzo LE, Castonguay A, Doyon N, Zhang W, Godin AG, Mohr D, Beggs S, Vandal K, Beaulieu JM, Cahill CM, Salter MW, De Koninck Y. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl? homeostasis. Nat Neurosci. 2013 Feb;16(2):183-92. doi: 10.1038/nn.3295
  17. Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298
  18. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993 Nov;77(5):1048-56. doi: 10.1213/00000539-199311000-00030
  19. Schug S, Palmer G, Scott D, Hallivell R, Trinca J. Acute Pain Management: Scientific Evidence. Australian and New Zeland College of Anaesthetists. 4-th ed. Melbourne; 2015. 647 p. http://fpm.anzca.edu.au/documents/apmse4_2015_final
  20. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008
  21. Hakkarainen TW, Steele SR, Bastaworous A, Dellinger EP, Farrokhi E, Farjah F, Florence M, Helton S, Horton M, Pietro M, Varghese TK, Flum DR. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington State’s Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg. 2015 Mar 1;150(3):223-28. doi: 10.1001/jamasurg.2014.2239
  22. Kotagal M, Hakkarainen TW, Simianu VV, Beck SJ, Alfonso-Cristancho R, Flum DR. Ketorolac Use and Postoperative Complications in Gastrointestinal Surgery. Ann Surg. 2016 Jan;263(1):71-5. doi: 10.1097/SLA.0000000000001260
  23. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013 Jun;21(3):201-32. doi: 10.1007/s10787-013-0172-x
  24. Volkov PA. Churadze BT, Sevalkin SA. Volkova YN, Guryanov VA. Dexmedetomidine as a part of analgesic component of general anesthesia for laparoscopic operations. Anesteziologiia i Reanimatologiia. 2015;60(1):4-8. https://cyberleninka.ru/article/n/deksmedetomidin-kak-sostavlyayuschaya-analgeticheskogo-komponenta-obschey-anestezii-pri-laparoskopicheskih-operatsiyah (In Russ.)
  25. Le Bot A, Michelet D, Hilly J, Maesani M, Dilly MP, Brasher C, Mantz J, Dahmani S. Efficacy of intraoperative dexmedetomidine compared with placebo for surgery in adults: a meta-analysis of published studies. Minerva Anestesiol. 2015 Oct;81(10):1105-17. doi: 10.1007/s40122-016-0045-2
  26. Davy A, Fessler J, Fischler M, LE Guen M. Dexmedetomidine and general anesthesia: a narrative literature review of its major indications for use in adults undergoing non-cardiac surgery. Minerva Anestesiol. 2017 Dec;83(12):1294-1308. doi: 10.23736/S0375-9393.17.12040-7
  27. Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011 Jul;27(3):297-302. doi: 10.4103/0970-9185.83670
  28. Kimura M, Saito S, Obata H. Dexmedetomidine decreases hyperalgesia in neuropathic pain by increasing acetylcholine in the spinal cord. Neurosci Lett. 2012 Oct 31;529(1):70-74. doi: 10.1016/j.neulet.2012.08.008
  29. Lee C, Kim YD, Kim JN. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol. 2013 Apr;64(4):301-7. doi: 10.4097/kjae.2013.64.4.301
  30. Schnabel A, Meyer-Frießem CH, Reichl SU, Zahn PK, Pogatzki-Zahn EM. Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta-analysis of randomized controlled trials. Pain. 2013 Jul;154(7):1140-49. doi: 10.1016/j.pain.2013.03.029
  31. Epshtoin SL, Azarova TM. Storozhev VYu, Vduvin VV, Sablin IA, Romanov BV, Martynov AN. General anesthesia without opioids in surgery for morbid obesity. What for and how? Regionarnaia Anesteziia i Lechenie Ostroi Boli. 2016;10(1). doi: 10.18821/1993-6508-2016-10-1-47-54 (In Russ.)
  32. Balandin VV, Gorobec ES. Opioid-free anesthesia, analgesia and sedation in surgery of head and neck tumors. Anesteziologiia i Reanimatologiia. 2015;60(6):39-42. https://cyberleninka.ru/article/n/bezopioidnaya-anesteziya-analgeziya-i-sedatsiya-v-hirurgii-opuholey-golovy-i-shei (In Russ.)
  33. De Kock M, Lavand’homme P, Waterloos H. ‘Balanced analgesia’ in the perioperative period: is there a place for ketamine? Pain. 2001 Jun;92(3):373-80. doi: 10.1016/S0304-3959(01)00278-0
  34. McCartney CJ, Sinha A, Katz J. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg. 2004 May;98(5):1385-400. doi: 10.1213/01.ane.0000108501.57073.38
  35. Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004603. doi: 10.1002/14651858.CD004603.pub2
  36. Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007 Jun;104(6):1545-56, table of contents. doi: 10.1213/01.ane.0000261517.27532.80
  37. Clivatti J, Sakata RK, Issy AM. Review of the use of gabapentin in the control of postoperative pain. Rev Bras Anestesiol. 2009 Jan-Feb;59(1):87-98. 10.1590/S0034-70942009000100012 [Article in English, Portuguese]
  38. Lauretti GR. Mechanisms of analgesia of intravenous lidocaine. Rev Bras Anestesiol. 2008 May-Jun;58(3):280-86. doi: 10.1590/S0034-70942008000300011 [Article in English, Portuguese]
  39. Finnerup NB, Biering-Sørensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH, Bach FW, Jensen TS. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology. 2005 May;102(5):1023-30. doi: 10.1097/00000542-200505000-00023
  40. Hollmann MW, Gross A, Jelacin N, Durieux ME. Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology. 2001 Jul;95(1):113-22. doi: 10.1097/00000542-200107000-00021
  41. Biella G, Sotgiu ML. Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord. Brain Res. 1993 Feb 19;603(2):201-6. doi: 10.1016/0006-8993(93)91238-n
  42. Cohen SP, Mao J. Is the analgesic effect of systemic lidocaine mediated through opioid receptors? Acta Anaesthesiol Scand. 2003 Aug;47(7):910-11. doi: 10.1034/j.1399-6576.2003.00163.x
  43. McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010 Jun 18;70(9):1149-63. doi: 10.2165/10898560-000000000-00000
  44. Marret E, Rolin M, Beaussier M, Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008 Nov;95(11):1331-38. doi: 10.1002/bjs.6375
  45. Sawyer J, Morningstar B, Chung F, Siddiqui N, McCluskey S. Enhanced Recovery after Surgery Guideline: Perioperative Pain Management in Patients Having Elective Colorectal Surgery. A Quality Initiative of the Best Practice in General Surgery Part of CAHO’s ARTIC program [Internet]. Toronto; 2013. Available from: https://www.sages.org/wpcontent/uploads/2013/09/toronto-iERAS_Pain_Mangement _Guideline_March_2014.pdf
  46. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002 Nov;195(5):694-12. doi: 10.1016/S1072-7515(02)01491-6
  47. Chin R Jr. Corticosteroids. In: Chernow B, ed. The pharmacologic approach to the critically ill patient. United States: Williams and Wilkens; 1988. p. 559-83.
  48. Buvanendran A, Kroin JS. Useful adjuvants for postoperative pain management. Best Pract Res Clin Anaesthesiol. 2007 Mar;21(1):31-49. doi: 10.1016/j.bpa.2006.12.003
  49. Batistaki C, Kaminiotis E, Papadimos T, Kostopanagiotou G. A Narrative Review of the Evidence on the Efficacy of Dexamethasone on Postoperative Analgesic Consumption. Clin J Pain. 2017 Nov;33(11):1037-46. doi: 10.1097/AJP.0000000000000486
  50. Ovechkin AM, Iavorovskii AG. Bezopioidnaia analgeziia v sovremennoi khirurgii – ot teorii k praktike. Moscow, RF: GEOTAR-Media; 2019. 234 p. http://www.geotar.ru/lots/NF0013030.html (In Russ.)
Address for correspondence:
119991, The Russian Federation,
Moscow, Trubetskaya Str., 8-2,
I.M. Sechenov First Moscow
State Medical University,
Department of Anesthesiology and Resuscitation
Tel.: +7 (916) 143-96-21,
e-mail: ovechkin_alexei@mail.ru,
Àlexei M. Ovechkin
Information about the authors:
Ovechkin Àlexei M., MD, Professor of the Department of Anesthesiology and Resuscitation, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0002-3453-8699
Sokologorskiy Sergey V., MD, Professor of the Department of Anesthesiology and Resuscitation, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0001-6805-9744
Politov Mikhail E., PhD, Associate Professor of the Department of Anesthesiology and Resuscitation, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0003-0623-4927
Contacts | ©Vitebsk State Medical University, 2007-2023